VCEL

ZERBE ROBERT L MD

CIK: 0001220363

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Truist lowers Vericel price target to $52. Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.

this person other insiders at VCEL

Transaction History

VCEL▲ Buy—
VCEL▲ Buy—
VCEL▲ Buy$33K
VCEL▼ Sell$156K
VCEL▲ Buy$33K
VCEL▼ Sell$150K
VCEL▲ Buy$33K
VCEL▼ Sell$144K
VCEL▲ Buy$33K
VCEL▼ Sell$138K
VCEL▲ Buy—
VCEL▲ Buy$12K
VCEL▼ Sell$169K
VCEL▲ Buy$3K
VCEL▼ Sell$36K
VCEL▼ Sell$102K
VCEL▼ Sell$9K
VCEL▼ Sell$103K
VCEL▼ Sell$105K
VCEL▲ Buy$12K
VCEL▼ Sell$126K
VCEL▼ Sell$84K
VCEL▼ Sell$8K
VCEL▼ Sell$4K
VCEL▼ Sell$39K
VCEL▼ Sell$108K
VCEL▲ Buy—
VCEL▲ Buy$32K
VCEL▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.